Clinical Trial Update: A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating safety and efficacy of oral MDV3100 in chemotherapy-naive patients with progressive metastatic prostate cancer has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• MDV3100 (enzalutamide)

Snippet

Sponsor: Pfizer | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-10-16